LY-3358966

N/A

Report date: 2025/01/26 18:37:48
NME

Base Information

Drug NameLY-3358966
Drug Alias Namesodium phosphate cotransporter 2B inhibitor (Eli Lilly)LY-3358966
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-dependent phosphate transport protein 2B inhibitors
TargetsSodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsHyperphosphatemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A